Correlation Between Energenesis Biomedical and Argosy Research

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Energenesis Biomedical and Argosy Research at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Energenesis Biomedical and Argosy Research into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Energenesis Biomedical Co and Argosy Research, you can compare the effects of market volatilities on Energenesis Biomedical and Argosy Research and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Energenesis Biomedical with a short position of Argosy Research. Check out your portfolio center. Please also check ongoing floating volatility patterns of Energenesis Biomedical and Argosy Research.

Diversification Opportunities for Energenesis Biomedical and Argosy Research

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Energenesis and Argosy is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Energenesis Biomedical Co and Argosy Research in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Argosy Research and Energenesis Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Energenesis Biomedical Co are associated (or correlated) with Argosy Research. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Argosy Research has no effect on the direction of Energenesis Biomedical i.e., Energenesis Biomedical and Argosy Research go up and down completely randomly.

Pair Corralation between Energenesis Biomedical and Argosy Research

Assuming the 90 days trading horizon Energenesis Biomedical Co is expected to under-perform the Argosy Research. But the stock apears to be less risky and, when comparing its historical volatility, Energenesis Biomedical Co is 1.01 times less risky than Argosy Research. The stock trades about -0.01 of its potential returns per unit of risk. The Argosy Research is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  7,434  in Argosy Research on September 12, 2024 and sell it today you would earn a total of  8,316  from holding Argosy Research or generate 111.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy78.96%
ValuesDaily Returns

Energenesis Biomedical Co  vs.  Argosy Research

 Performance 
       Timeline  
Energenesis Biomedical 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Energenesis Biomedical Co are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Energenesis Biomedical is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Argosy Research 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Argosy Research are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Argosy Research may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Energenesis Biomedical and Argosy Research Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Energenesis Biomedical and Argosy Research

The main advantage of trading using opposite Energenesis Biomedical and Argosy Research positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Energenesis Biomedical position performs unexpectedly, Argosy Research can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Argosy Research will offset losses from the drop in Argosy Research's long position.
The idea behind Energenesis Biomedical Co and Argosy Research pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities